Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.64 |
| ▸ | PNP | P00491 | 1/20 | 0.48 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.44 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.41 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.41 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.41 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.41 |
| ▸ | GDA | Q9Y2T3 | 2/20 | 0.40 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | XDH | P47989 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | DPP4 | P27487 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1230978 | 0.85 | ALDH1A1 (0.61) | ALDH1A1PNPPDPK1GRIA1GRIA2 | |
| Hypoxanthine SCHEMBL25381 | 0.79 | ALDH1A1 (1.00) | ALDH1A1PNPPDPK1GRIA1GRIA2 | |
| Hypoxanthine SCHEMBL30096461 | 0.79 | ALDH1A1 (1.00) | ALDH1A1PNPPDPK1GRIA1GRIA2 | |
| Hypoxanthine SCHEMBL7037918 | 0.79 | ALDH1A1 (1.00) | ALDH1A1PNPPDPK1GRIA1GRIA2 | |
| Hypoxanthine SCHEMBL28774651 | 0.77 | ALDH1A1 (0.95) | ALDH1A1PNPPDPK1GRIA1GRIA2 | |
| Hypoxanthine SCHEMBL122843 | 0.77 | ALDH1A1 (0.95) | ALDH1A1PNPPDPK1GRIA1GRIA2 | |
| Hypoxanthine SCHEMBL560392 | 0.77 | ALDH1A1 (0.95) | ALDH1A1PNPPDPK1GRIA1GRIA2 | |
| Hypoxanthine SCHEMBL30703487 | 0.77 | ALDH1A1 (0.95) | ALDH1A1PNPPDPK1GRIA1GRIA2 | |
| Hypoxanthine SCHEMBL2639254 | 0.77 | ALDH1A1 (0.95) | ALDH1A1PNPPDPK1GRIA1GRIA2 | |
| Hypoxanthine SCHEMBL7168422 | 0.77 | ALDH1A1 (0.95) | ALDH1A1PNPPDPK1GRIA1GRIA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260078158-A1 | COMPOSITIONS COMPRISING CXCL10-DERIVED PEPTIDES AND METHODS OF USE THEREOF | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2026-03-19 | — | — | US | claimed |
| CN-119269680-A | Metabolic marker for diagnosing abdominal aortic aneurysm and application thereof | 首都医科大学附属北京友谊医院 | 2025-01-07 | — | — | CN | claimed |
| WO-2024050567-A2 | COMPOSITIONS COMPRISING CXCL10-DERIVED PEPTIDES AND METHODS OF USE THEREOF | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2024-03-07 | — | — | WO | claimed |
| CN-111971291-A | Cyclic dinucleotide compounds containing 2-aza-hypoxanthine or 6H-pyrazolo [1,5-D ] [1,2,4] triazin-7-one as STING agonists | 勃林格殷格翰国际有限公司 | 2020-11-20 | — | — | CN | claimed |
| WO-2019172268-A1 | PLANT DISEASE CONTROL AGENT | 国立大学法人静岡大学 | 2019-09-12 | — | — | WO | claimed |
| US-8518859-B2 | Method for increasing yield of staple food crop | NATIONAL UNIVERSITY CORPORATION SHIZUOKA UNIVERSITY (JP) | 2013-08-27 | — | — | US | claimed |
| US-20120122690-A1 | Method For Increasing Yield Of Staple Food Crop | NATIONAL UNIVERSITY CORPORATION SHIZUOKA (JP) | 2012-05-17 | — | — | US | claimed |
| JP-11278977-A | — | — | None | — | — | JP | disclosed |
| EP-4735593-A1 | POLYNUCLEOTIDE SYNTHESIS METHOD, KIT AND SYSTEM | Oxford Nanopore Technologies PLC (GB) | 2026-05-06 | — | — | EP | disclosed |
| US-20260078158-A1 | COMPOSITIONS COMPRISING CXCL10-DERIVED PEPTIDES AND METHODS OF USE THEREOF | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2026-03-19 | — | — | US | disclosed |
| US-12527801-B2 | Cell activator of animal cell | VITAMIN C60 BIORESEARCH CORPORATION (JP) | 2026-01-20 | — | — | US | disclosed |
| US-20250382344-A1 | Soluble GLP1/GIP/NPY2 Receptor Triple Agonists | BOEHRINGER INGELHEIM INT GMH (DE) | 2025-12-18 | — | — | US | disclosed |
| CN-120192429-A | DHODH polypeptide degradation agent and application thereof in preparation of medicine for preventing and/or treating DHODH-mediated diseases | 华东理工大学 | 2025-06-24 | — | — | CN | disclosed |
| EP-1353924-A1 | SYNTHESIS OF TEMOZOLOMIDE AND ANALOGS | Schering Corporation (US) | 2003-10-22 | — | — | EP | disclosed |
| US-6458796-B1 | METHOD OF TREATING CARDIOVASCULAR DISORDERS, THROMBOEMBOLIC DISORDERS AND ISCHAEMIAS, AND UROGENITAL SYSTEM DISORDERS, COMPRISING ADMINISTERING TO MAMMALS | BAYER AKTIENGESELLSCHAFT (DE) | 2002-10-01 | — | — | US | disclosed |
| WO-2002057269-A1 | SYNTHESIS OF TEMOZOLOMIDE AND ANALOGS | SCHERING CORPORATION (US) | 2002-07-25 | — | — | WO | disclosed |
| US-20020095036-A1 | Synthesis of temozolomide and analogs | SCHERING CORPORATION | 2002-07-18 | — | — | US | disclosed |
| EP-1214331-A2 | 2-AZAPURINE COMPOUNDS AND THEIR USE | Roche Diagnostics GmbH (DE) | 2002-06-19 | — | — | EP | disclosed |
| WO-2001016149-A2 | 2-AZAPURINE COMPOUNDS AND THEIR USE | ROCHE DIAGNOSTICS GMBH (DE) | 2001-03-08 | — | — | WO | disclosed |
| JP-H11278977-A | GAS GENERATOR COMPOSITION | DAICEL CHEM IND LTD | 1999-10-12 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120122690-A1 | Method For Increasing Yield Of Staple Food Crop | SI, H1-0, H1-3 | ALDH1A1 4642/4885PNP 4258/4885PDPK1 2241/4885 |
| US-12527801-B2 | Cell activator of animal cell | DSG1, DSC1, KRT18 | ALDH1A1 2037/4885PNP 4733/4885PDPK1 844/4885 |
| US-20250382344-A1 | Soluble GLP1/GIP/NPY2 Receptor Triple Agonists | GLP1R, GIPR, NPY1R | ALDH1A1 4727/4885PNP 3994/4885PDPK1 1393/4885 |
| US-20260078158-A1 | COMPOSITIONS COMPRISING CXCL10-DERIVED PEPTIDES AND METHODS OF USE THEREOF | CXCL10, CCL2, CXCR3 | ALDH1A1 4811/4885PNP 4078/4885PDPK1 4329/4885 |
| US-20020095036-A1 | Synthesis of temozolomide and analogs | MGMT, TYMS, MCL1 | ALDH1A1 1791/4885PNP 759/4885PDPK1 1231/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.